Research Line

Integrated approach to personalized cancer diagnosis and therapy /
Medical Oncology

Solid neoplasms
Research is mainly oriented toward new molecular-targeted therapies (target therapy) and the testing of new organizational models for humanizing care. In particular, it focuses on the study of breast, gastroenteric, thoraco-pulmonary, head-neck, urologic, and skin neoplasms in both early and advanced stages. In this area, the research team participates in and promotes numerous clinical and translational research trials.

  • Institute of Cancer Research, Royal Marsden Hospital, Imperial College (Londra)
  • Institute J Bordet (Bruxelles)

6 oncologists, 3 study coordinators